Company: CERO
Filing Date: 2025-08-22
Form Type: 424B3
Source: 0001213900-25-080017
Chunk: 13

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-22
Form: 424B3
Chunk 13
---
              |   |
| Basic and diluted                                          |     |            |      488,076 |   |     |            |        8,099 |   |     |            |     330,603 |   |     |            |        7,859 |   |     |              |          292 |   |

<div align='center'>See accompanying notes to the condensed consolidated financial statements

Reflects a 1-for-100 reverse stock split effective January 8, 2025 and 1-for-20 reverse stock split effective June 13, 2025

2

CERO THERAPEUTICS HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT

(Unaudited)</div>

|                                                                                                        |     | Convertible Preferred Stock 
 Series A                    
 Shares                      |        |   |     | Amount |           |   |     | Series B 
 Shares   |      |   |     | Amount |          |   |     | Series C 
 Shares   |        |   |     | Amount |           |   |     | Series D 
 Shares   |       |     | Amount |           |     | Series A     
 Common Stock 
 Shares       |           |     | Amount |     |     | Additional 
 Paid-in    
 Capital    |            |   |     | Stock         
 Subscriptions 
 Receivable    |            |   |     | Accumulated 
 Deficit     |             |   |     | Total         
 Stockholders’ 
 Deficit       |            |   |
|:-------------------------------------------------------------------------------------------------------|:----|:----------------------------|-------:|:--|:----|:-------|----------:|:--|:----|:---------|-----:|:--|:----|:-------|---------:|:--|:----|:---------|-------:|:--|:----|:-------|----------:|:--|:----|:---------|------:|:----|:-------|----------:|:----|:-------------|----------:|:----|:-------|----:|:----|:-----------|-----------:|:--|:----|:--------------|-----------:|:--|:----|:------------|:------------|:--|:----|:--------------|-----------:|:--|
| Balance at December 31, 2024 (Successor)                                                               |     |                             |  1,894